VEGFA and neoplasm: One reason might be that the tumour VEGF levels after cisplatin treatment in B16 tumours are generally higher (Supplementary Fig. 1A) than in LLC tumours (Fig. 2a) and, therefore, endothelial chemerin release is still repressed in B16 tumours.